Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re Director Share Purchases and Correction

10 Nov 2014 07:00

RNS Number : 5552W
Quindell PLC
10 November 2014
 



 

Quindell Plc ("Quindell", the "Company" or the "Group")

Further re Director Share Purchases and Correction

 

On 5th November 2014, the Company announced that three directors of the Company, Robert Terry, Laurence Moorse, and Steve Scott ("the Purchasing Directors") had entered into agreements with Equities First Holdings LLC ("EFH") (the "Agreements" or "Agreement" as the case may be) (the "Announcement"). The Announcement stated that the Purchasing Directors had entered into the Agreements to facilitate the initial purchase, in aggregate, of 1,575,000 ordinary shares of 15 pence each in the Company ("Ordinary Shares"). It was announced on 7th November 2014, that a further purchase of 175,000 Ordinary Shares had been made by Bickleigh Ridge Limited, a company controlled by Steve Scott and his immediate family, such purchase also having been financed pursuant to an Agreement with EFH (the "Further Announcement").

 

Clarification

Whilst the Board of Quindell (the "Board") understands that the Announcement followed a format consistent with announcements made by other AIM companies where directors had entered into similar arrangements with EFH, the Board wishes to provide further disclosure and clarification in relation to the Agreements as referred to in the Announcement and Further Announcement. Terms defined in the Announcement have the same meanings in this one.

 

Under the Agreement, which is a sale and repurchase agreement intended to provide financing to the Purchasing Directors, the Purchasing Directors transferred the legal and beneficial interest in a number of shares to EFH (the "transferred shares") in return for the Purchasing Directors receiving a payment from EFH of a sum equal to 67 per cent of the three-day average market value per share less a financing arrangement fee of 3 per cent. (the "EFH Purchase Price"). Further details of the transfers made are set out in the table below. As the legal and beneficial holder of the transferred shares, EFH may take any action it deems appropriate in relation to the transferred shares and is under no obligation to hold or retain the transferred shares though it has undertaken not to vote them. In addition, EFH has represented and warranted to the Purchasing Directors that it will not borrow Ordinary Shares for short selling activities and that its broker/ dealer or depository institutions will not engage in any short selling activity with any shares transferred under the Agreement and held on account by them.

 

On the maturity date of the Agreement (two years from the payment of the EFH Purchase Price), the Purchasing Directors are contractually obliged and have informed the Company that they fully intend to, purchase the transferred shares or equivalent shares from EFH at a price equal to 69 per cent. of the three-day average market value per share applicable at the date of entering into the facility, less margin calls paid, and EFH is required to deliver the transferred shares or equivalent shares to each Purchasing Director on payment.

 

If, prior to the maturity date, the value of the transferred shares falls to 80 per cent. or less of the value at which they were transferred to EFH, being 67 per cent. of the three-day average market value at the time when the relevant transfer was made, the Purchasing Directors will be required to transfer further Ordinary Shares or provide cash to satisfy margin calls. In the event that any further Ordinary Shares are transferred to EFH pursuant to the Agreements, or any similar agreements are entered into, a further announcement will be made.

 

  

Correction of Rights

The table below is a restatement of certain information contained in the Announcement and has been expanded to incorporate a correction that reflects the timing of the transfer of Ordinary Shares to EFH, which the Purchasing Directors have been advised should be regarded as having occurred on 5 November 2014, when the facility monies were advanced. The Purchasing Directors remain interested in the transferred shares by reason of the repurchase obligation contained in the Agreements. Further announcements will be made on each occasion that Ordinary Shares are transferred under the Agreements.

 

 

Name/position

No. of Ordinary Shares prior to transfer of shares under facility

No. of Ordinary Shares transferred to EFH pursuant to the facility(and to be repurchased)

to date

Aggregate EFH Purchase Price, less 3 per cent facility fee

(£)

 No. of Ordinary Shares purchased and average price paid

No. of Ordinary Shares with voting rights held after transactions and as a % of the Company

Total interest in Ordinary Shares and as a % of the Company (2)

 

Robert Terry,

 Chairman

45,650,000(1)

8,850,000(2)

7,465,596

1,000,000 at 123.47p

37,800,000(1) (8.66%)

46,650,000 (1) (10.69%)

Laurence Moorse, Group Finance Director

1,196,666

200,000(2)

168,714

50,000

at 123.00p

1,046,666 (0.24%)

1,246,666 (0.29)%

Steve Scott,

525,000(1)

at 123.83p

and

175,000(1)

at 120.88p

Non-Executive Director

5,112,992(1)

1,350,000(2)

1,138,820

4,462,992(1) (1.02%)

5,812,992(1) (1.33%)

The total issued ordinary share capital of the Company comprises 436,345,424 Ordinary Shares.

(1) Includes Ordinary Shares held as family interests or by virtue of position as beneficiary or potential beneficiaries of certain trusts or companies.

(2) As stated above, under the Agreements the Directors have agreed to repurchase the transferred shares or equivalent shares at a price calculated by reference to the value at the time of the Agreements at the end of the two year period. For this reason the Directors continue to have an interest in these Ordinary Shares and they are therefore included in their total interest in Ordinary Shares.

 

 

Robert Terry, Chairman of Quindell said: "As previously stated and as demonstrated by the initial purchases made by the Purchasing Directors and the fact that the majority of the board has acquired shares recently, we believe the current market valuation of the Company is materially below its true value.

 

In entering into the sale and repurchase agreements to provide finance, each of us Purchasing Directors relied upon assurances from EFH that, notwithstanding EFH's legal rights, the custom and practice of EFH was that the shares transferred would not be disposed of outright, other than in a default event and will be held by their custodians throughout the term of the agreement, nor would they engage in short selling activity.

 

We have made this further announcement to ensure the market is aware of the actual number of shares transferred to date under the Agreements. Further announcements will be made when more shares are to be used to fund further purchases of Quindell shares in the future. For clarity, purchasing shares at the current valuation has been the motivation for entering into the Agreements. The Agreements are purely to provide funding for a two year term and I and Laurence intend to use the funds received under the Agreement to purchase Quindell shares and to cover any associated potential tax liabilities and margin calls relating to the Agreements, with Steve Scott intending to do the same and also cover certain other tax liabilities.

 

The Agreements would not have been entered into if the board did not remain confident of meeting full year market expectations and of the Company's longer term prospects."

 

For further information:

 

Quindell PlcRobert Terry, Chairman

 

Laurence Moorse, Group Finance Director

 

Stephen Joseph, Head of Investor Relations

 

Tel: 01489 864201

terryr@quindell.com

Tel: 01489 864205

moorsel@quindell.com

Tel: 01489 864200

josephs@quindell.com

 

 

Cenkos Securities plcJoint Broker and Nominated AdviserStephen Keys/Mark Connelly

 

Canaccord Genuity Limited

Joint Broker and Financial Adviser

Simon Bridges/Bruce Garrow

 

 

Tel: 020 7397 8900

 

 

Tel: 020 7523 8000

 

 

 

Media EnquiriesRedleaf Polhill Limited

Rebecca Sanders-Hewett/Jenny Bahr

 

Bell Pottinger

Victoria Geoghegan/Will Powell

 

Tel: 020 7382 4730

quindell@redleafpr.com

 

 

Tel: 020 3772 2562

Quindell@bellpottinger.com

 

 

For further information, please visit www.quindell.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQKKDQNBDKKDD
Date   Source Headline
5th Dec 201110:54 amPRNForm 8.3 - Quindell Portfolio Plc
5th Dec 20119:58 amRNSForm 8.3 - Quindell Portfolio Plc
5th Dec 20117:00 amRNSRule 2.10 Announcement
2nd Dec 20111:39 pmRNSEarly settlement of TMS Earnout
2nd Dec 20117:00 amRNSRecommended Share Offer for Mobile Doctors
1st Dec 201110:58 amRNSForm 8.3 - Quindell Portfolio Plc
30th Nov 20112:00 pmRNSTotal Voting Rights
29th Nov 201110:36 amRNSForm 8.3 - Quindell Portfolio Plc
28th Nov 20119:07 amRNSForm 8.3 - Quindell Portfolio Plc
25th Nov 20113:54 pmRNSTMC (Southern) Ltd - Form 8.3 - Quindell
25th Nov 201110:40 amRNSForm 8.3 - Quindell Portfolio Plc
18th Nov 20117:00 amRNSAppointment of Joint Broker
17th Nov 20115:32 pmRNSForm 8 (OPD) Mobile Doctors Group Plc
17th Nov 20114:38 pmRNSJohn Stretton-Knowles - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMatthew Whiting - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSNeil McGrigor - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMark Read - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSSimon Rand - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTony Smith - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSJames Eneas - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSDominic Milton - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTMC (Southern) Limited - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSBradley Wingrave - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSForm 8 (OPD) (Quindell Portfolio Plc)
17th Nov 20114:37 pmRNSForm 8 (OPD) (Mobile Doctors)
17th Nov 20114:37 pmRNSRule 2.10 Announcement
10th Nov 20117:00 amRNSPartnership with SMI Telecoms LLC
7th Nov 20112:57 pmRNSForm 8.3 - Quindell Portfolio Plc
4th Nov 20119:54 amRNSPossible Offer for Mobile Doctors
1st Nov 20117:00 amRNSAcquisition of Maine Finance Limited
31st Oct 20117:00 amRNSTotal Voting Rights
26th Oct 20117:00 amRNSIntegration of Acquired Businesses
21st Oct 201110:58 amRNSDirector Shareholdings/Significant Shareholders
19th Oct 201110:56 amRNSDirector/PDMR Shareholding
19th Oct 20119:56 amRNSDirector/PDMR Shareholding
19th Oct 20117:00 amRNSFurther Investment in Mobile Doctors Group plc
17th Oct 201110:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSSeven new Contract wins and Trading Update
10th Oct 20117:10 amRNSFurther Investment in Mobile Doctors Group plc
10th Oct 20117:00 amRNSAppointment of Financial PR Advisor
1st Aug 20117:00 amRNSTotal Voting Rights
25th Jul 20117:01 amRNSDirector/PDMR Shareholding
25th Jul 20117:01 amRNSInvestment in MDG.L and Board Appointment
25th Jul 20117:00 amRNSHalf Yearly Report
22nd Jul 20117:00 amRNSAcquisition
21st Jul 20117:00 amRNSInvestment in digital insurance brand Ingenie
18th Jul 20117:00 amRNSChange of Name
14th Jul 201111:24 amRNSIssue of Warrants
14th Jul 201111:23 amRNSResults of General Meeting
11th Jul 20114:02 pmRNSChanges to significant shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.